Tag Archives: Clinical

WorkForce Redefined – Collaboration at Healthcare sector and Information Technology level

As the digital revolution gains momentum, doctors, scientists, life sciences and people from different walks of life and other professionals are using machines to be more efficient, powerful, trust worthy and these machines are often now used for getting better decisions and to take on complex tasks.

How machines have gained trust over manual work and efficiency

Augmented devices providing more portability, insights, platform to provide and make available on clicks the huge database of contextual information and research outputs from various industries. Such grounds on cloud facility has indeed helped market research professionals and companies, doctors, scientists, clinical trial process during the entire process. It has helped people from all over the world to click share and connect for advice in quick time to take decisions.

Training of people on machines and technology are equally important

This bullish trend of digitization and evolution of machines into the mainstream of industries from scratch to the end has made this necessary for their people to have adequate knowledge of computer and machines in terms of operating and maintenance of the same.

Life Sciences industries increasing the scope of operations

This growing trend illustrates that how life sciences companies must and should embrace digital way to go beyond the imagination with the goal of meeting the need of society.

Find Genetic Drift on: WordPress  Twitter  Pinterest   Tumblr   Academia


Clinical trials in India are good or bad?

These days, IRB and other boards have tightened their rules and regulations to implement in India while conducting clinical trials at any part of the India. India, China, African regions have had been a hub for conducting clinical trials in human for bulk. It was recently, that rules have been revised and it has got difficult for foreign investors and institutes to conduct trials in India. As, it resulted in many innocent deaths. But the figure mentioned against the number of deaths was not true.

As majority of the patients died due to their persistent illness. We people do agree, that at certain points it has caused some harm to people, but upto some extent it is expected. And the main agenda behind this is to get some effective drug to cure diseases. Though India has been in this ground for the last many decades and this is the reason, Indian people especially from the poor side has availed many drugs for free and their diseases have been cured.

India is a developing country and we need drugs at a whole for our poor people. They do not have access to many of the mandatory drugs and vaccines that one should get at the time of birth and till baby attains immunity against most of the deadliest diseases. We suggest that investors should invest and IRB should give them grounds to plan their trials, but under the proper guidance and observation of the boards and courts. So that death rates can be reduced.

Find me on: WordPress  Twitter  Pinterest   Tumblr   Academia